Atosky-20 Tablets provide an established, clinically unified lipid-lowering and cardiovascular protection therapy carefully developed for the continuous management, long-term stabilization, and arterial optimization of patients navigating hyperlipidemia and progressive atherosclerotic risks. In conditions of unmanaged cholesterol, high volumes of low-density lipoprotein (LDL) circulate within the bloodstream, gradually infiltrating vascular walls. Over time, these lipids oxidize, triggering localized inflammatory responses that build rigid, fatty plaques. This structural narrowing restricts vital blood velocity profiles and sets the baseline risk for acute cardiovascular blockages. This advanced formulation delivers a potent structural statin within a standard 20 mg unit to restore balanced systemic lipid metrics safely over an ongoing chronic care routine.
The active component, Atorvastatin (20 mg), functions dynamically via highly targeted hepatic pathways:
-
Competitive Inhibition of HMG-CoA Reductase: It operates as a highly selective, competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A ($HMG\text{-}CoA$) reductase. This rate-limiting enzyme governs the metabolic conversion of $HMG\text{-}CoA$ to mevalonate, an absolute prerequisite precursor for internal cholesterol synthesis inside the liver.
-
LDL Receptor Upregulation & Clearance: Dropping internal hepatic cholesterol pools triggers a compensatory reflex, prompting hepatocytes to express high volumes of high-affinity LDL receptors on their surface membranes. These expanded receptor fields actively capture and clear circulating LDL and Very-Low-Density Lipoprotein ($VLDL$) fractions out of the plasma, systematically reducing atherogenic particle numbers around the clock.
Key Benefits
-
Comprehensive Lipid Profiling: Aggressively drives down total cholesterol, bad cholesterol (LDL), and triglycerides while systematically improving protective good cholesterol (HDL) markers.
-
Plaque Stabilization & Vascular Shielding: Exerts crucial pleiotropic benefits, meaning it stabilizes existing arterial walls, dampens vascular inflammation, and prevents fatty plaques from rupturing.
-
Clinically Proven Heart Protection: Statistically recognized to markedly minimize the risk of suffering secondary strokes or acute myocardial infarctions.
-
Extended Circulatory Performance: Atorvastatin possesses a long therapeutic half-life with active metabolites, ensuring continuous, round-the-clock enzyme inhibition.
-
Trusted Quality Engineering: Manufactured under strict pharmaceutical protocols of DH, ensuring exceptional tablet dissolution uniformity and steady structural bioavailability.
Directions for Use
-
Take exactly as directed by your cardiologist, endocrinologist, or primary healthcare specialist.
-
Atosky-20 is strictly administered as a single tablet once daily, taken at the exact same hour every single day.
-
Can be taken comfortably either with or without food. While it can be taken at any time of day due to its long duration of action, consistency in timing is critical to preserve a perfectly flat therapeutic baseline.
-
Swallow the tablet whole with a full glass of plain water. Do not crush, break, split, or chew it.
Safety & Precautions
-
Do not alter your daily schedule or stop usage suddenly without explicit confirmation from your specialist, as circulating cholesterol metrics can quickly relapse back to high-risk baselines.
-
STRICT PREGNANCY CONTRAINDICATION: Atosky-20 must strictly NEVER be utilized during pregnancy or by women planning a pregnancy. Cholesterol synthesis is indispensable for proper fetal development; statins can cause severe embryonic harm. Effective contraception must be used continuously throughout treatment.
-
CRITICAL SKELETAL MUSCLE WARNING (MYOPATHY): This class of medication carries a statistical risk of provoking muscle damage. Inform your specialist immediately if you experience unexplained muscle pain, tenderness, cramping, or generalized weakness, especially if accompanied by a high fever or dark, tea-colored urine (early indicators of rhabdomyolysis).
-
Liver Enzyme Tracking Parameter: This medication can cause elevations in serum transaminases. Baseline liver function tests (LFTs) should be performed prior to starting therapy and repeated periodically as clinically advised. Avoid heavy concurrent alcohol consumption to protect hepatic tissue tracking blocks.
-
Dietary Interaction Rule: Avoid drinking excessive volumes of grapefruit juice during therapy, as compounds in grapefruit can elevate blood levels of atorvastatin, increasing the risk of side effects.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 30°C.
-
Protect from direct sunlight exposure, intense radiator heat channels, and environmental room moisture pools.
-
Always keep the white tablets safely sealed inside their original protective Alu-Alu or blister packaging layout until the exact moment of intake to shield the core components from ambient moisture degradation.
